SALIX PHARMACEUTICALS LTD — key financial figures for fiscal year 2014 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2014)

$1.1B

Net Income/Loss (FY2014)

-$414.9M

Total Assets (FY2014)

$4.1B

Total Equity (FY2014)

$238.2M

Cash Flows from Operating Activities (FY2014)

$4.2M

Source: SALIX PHARMACEUTICALS LTD 10-K filing (FY2014). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.